Used in research as a potential inhibitor in signaling pathways related to inflammatory and oncogenic processes. Shows activity in modulating protein-protein interactions involved in cellular proliferation and immune response. Investigated for its role in targeted therapies, particularly in cancers where overexpression of specific transcription factors or kinases drives tumor growth. Its bivalent structure allows dual targeting of homologous binding sites, enhancing selectivity and potency in cellular assays. Primarily employed in preclinical studies to evaluate efficacy, pharmacokinetics, and mechanism of action in disease models. Not approved for clinical use; strictly for laboratory research.